AU

AngloGold Ashanti
D

AU

Arincen87/100B

AngloGold Ashanti stock forecast 2026–2030

Analysts' average 12-month price target for AngloGold Ashanti is 109.50, 17.7% above the current price of 93.02. Their targets range from 44.50 to 180.00.

Of the 7 firms that rated AngloGold Ashanti in the past 12 months, 6 rate it buy or strong buy, 1 hold and 0 sell or strong sell (each firm at its latest rating): a Strong buy consensus.

12-month price target
109.50 USD
+17.72%

Analysts' 1-year price targets range from 44.50 to 180.00, with an average of 109.50.

Past year
1-year forecast
Strong sellStrong buy
Strong buy
7 ratings
Strong buy
0
Buy
6
Hold
1
Sell
0
Strong sell
0

12-month price target

Highest target180.00
Average target109.50
Lowest target44.50
Current price93.02

AngloGold Ashanti price target history

Have analysts recently raised or lowered their AngloGold Ashanti price target and rating?

See how analysts moved their price target

How analysts rate AngloGold Ashanti, month by month

6 of 7 firms rate it buy now, against 5 of 6 in December 2025.

Buy Hold Sell

Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.

Month endBuyHoldSellFirms
Nov 20266107
Oct 20266107
Sept 20265106
Aug 20265005
Jul 20265005
Jun 20264004
May 20264004
Apr 20264004
Mar 20265016
Feb 20265016
Jan 20265016
Dec 20255016

AngloGold Ashanti analyst upgrades, downgrades and price targets

The latest rating change came on 10 September 2026, when BMO Capital downgraded AngloGold Ashanti from Outperform to Market Perform. Its price target is 115.00. The most recent new target came from RBC Capital on 20 October 2026: 44.50.

DateFirmRatingPrice targetChangePrice then
20 Oct 2026
RBC Capital
Gordon Ramsay
—111.00 → 44.50-59.9%91.52
15 Oct 2026
Goldman Sachs
—42.00 → 104.00+147.6%88.84

AngloGold Ashanti EPS and revenue estimates

Revenue

ReportedEstimate

EPS

ReportedEstimate
Fiscal yearEPSEPS growthEPS rangeRevenueRevenue growthRevenue rangeAnalysts
FY2028 (est.) 10.02+13.0%7.57 – 11.67 14.03B+6.8%11.54B – 19.43B4
FY2027 (est.) 8.87+2.2%7.54 – 9.60 13.13B+4.9%12.80B – 13.47B5
FY2026 (est.) 8.67+62.1%8.56 – 8.83 12.52B+28.2%12.49B – 12.56B4
FY2025 5.35+121.1%— 9.77B+36.7%——
FY2024 2.42-24.8%— 7.15B———
FY2013 3.22+28.3%— ————
FY2012 2.51—— 9.69B———

Does AngloGold Ashanti beat earnings estimates?

On average, analysts' EPS estimate was 27.5% off the result, either way, and their revenue estimate 10.9%, over the last 12 quarters.

EPS beats
28 / 79
Revenue beats
24 / 65
Average EPS surprise, last 12
-25.7%
Since
October 2001
QuarterReport dateEPS estimateReported EPSSurpriseRevenue estimateReported revenueSurprise
Q3 FY20265 Nov 20261.761.55-11.9%2.89B2.62B-9.4%
Q2 FY202631 Jul 20262.031.98-2.5%3.20B3.10B-3.0%
Q1 FY20268 May 20262.272.52+11.0%3.26B3.15B-3.2%
Q4 FY202520 Feb 20261.981.90-4.0%3.04B3.02B-0.7%
Q3 FY202511 Nov 20251.341.32-1.5%2.53B2.37B-6.3%
Q2 FY20251 Aug 20251.311.25-4.6%2.29B2.45B+6.9%
Q1 FY20259 May 20250.950.88-7.4%1.84B1.93B+4.7%
Q4 FY202419 Feb 20251.270.89-29.9%3.20B1.75B-45.3%
Q3 FY20247 Nov 20240.810.53-34.6%1.54B1.47B-4.8%
Q2 FY20246 Aug 20240.920.60-34.8%2.55B2.55B0.0%
Q1 FY202428 Jun 20241.230.40-67.5%2.45B1.38B-43.7%
Q4 FY202323 Feb 20241.23-0.25-120.3%2.45B2.40B-2.2%

AngloGold Ashanti stock price 2026–2030: scenarios

If AngloGold Ashanti's earnings keep growing at the 23.3% a year analysts expect to FY2028, it would earn about 15.23 a share in FY2030. At the P/E it has traded at over the last five years (9.9 to 35.3) that is 150.81 to 537.59 a share, or 289.34 at its average P/E of 19.0. This is arithmetic on the analysts' estimates, not a prediction.

Bull Base Bear
Fiscal yearEPSBearBaseBull
FY2026 8.6785.92164.84306.28
FY2027 8.8787.81168.47313.02
FY2028 10.0299.26190.43353.81
FY2029 (extrapolated)12.35122.35234.73436.12
FY2030 (extrapolated)15.23150.81289.34537.59

Each year's EPS is the analysts' consensus to FY2028; the years after continue its 23.3% a year. Bear, base and bull apply the lowest, average and highest P/E of the last five fiscal year ends (9.9, 19.0, 35.3).

Most undervalued US stocks

StockPriceFair valueUpside
99.090
195.09146Price 99.09244
+96.9%
186.680
359.93270Price 186.68450
+92.8%
213.670
405.66304Price 213.67507
+89.9%
161.160
305.51157Price 161.16396
+89.6%
42.225
79.0244Price 42.23157
+87.1%
160.650
299.85225Price 160.65375
+86.6%
108.445
201.41108Price 108.45248
+85.7%

Furthest below the fair value on each stock's page, updated every day.

Common questions about the AngloGold Ashanti stock forecast

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.